APO Research
Talk to an analyst

APO RESEARCH · REPORT

Imatinib Mesylate Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Imatinib Mesylate Drugs Market Analysis and Forecast 2026-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchImatinib Mesylate Drugs Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Imatinib Mesylate Drugs Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Imatinib Mesylate Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Imatinib Mesylate Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Imatinib Mesylate Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Imatinib Mesylate Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Imatinib Mesylate Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Imatinib Mesylate Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Imatinib Mesylate Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Imatinib Mesylate Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Imatinib Mesylate Drugs include Novartis. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Imatinib Mesylate Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Imatinib Mesylate Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Imatinib Mesylate Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Imatinib Mesylate Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Imatinib Mesylate Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Imatinib Mesylate Drugs sales, projected growth trends, production technology, application and end-user industry.

Imatinib Mesylate Drugs Segment by Company

Novartis

Imatinib Mesylate Drugs Segment by Type

100mg

400mg

Imatinib Mesylate Drugs Segment by Application

Hospital

Pharmacy

Imatinib Mesylate Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Imatinib Mesylate Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Imatinib Mesylate Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Imatinib Mesylate Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Imatinib Mesylate Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Imatinib Mesylate Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Imatinib Mesylate Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Imatinib Mesylate Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 100mg Major Manufacturers Table 3. 400mg Major Manufacturers Table 4. Global Imatinib Mesylate Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Pharmacy Major Manufacturers Table 7. Imatinib Mesylate Drugs Industry Trends Table 8. Imatinib Mesylate Drugs Industry Drivers Table 9. Imatinib Mesylate Drugs Industry Opportunities and Challenges Table 10. Imatinib Mesylate Drugs Industry Restraints Table 11. Global Imatinib Mesylate Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Imatinib Mesylate Drugs Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Imatinib Mesylate Drugs Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Imatinib Mesylate Drugs Revenue Market Share by Region (2021-2026) Table 15. Global Imatinib Mesylate Drugs Revenue Market Share by Region (2027-2032) Table 16. Global Imatinib Mesylate Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Imatinib Mesylate Drugs Sales by Region (2021-2026) & (k units) Table 18. Global Imatinib Mesylate Drugs Sales by Region (2027-2032) & (k units) Table 19. Global Imatinib Mesylate Drugs Sales Market Share by Region (2021-2026) Table 20. Global Imatinib Mesylate Drugs Sales Market Share by Region (2027-2032) Table 21. Global Imatinib Mesylate Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Imatinib Mesylate Drugs Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Imatinib Mesylate Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Imatinib Mesylate Drugs Sales Market Share by Manufacturers (2021-2026) Table 25. Global Imatinib Mesylate Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Imatinib Mesylate Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Imatinib Mesylate Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Imatinib Mesylate Drugs Manufacturers, Product Type & Application Table 29. Global Imatinib Mesylate Drugs Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Imatinib Mesylate Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Imatinib Mesylate Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Imatinib Mesylate Drugs Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Imatinib Mesylate Drugs Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Imatinib Mesylate Drugs Revenue Market Share by Type (2021-2026) Table 36. Global Imatinib Mesylate Drugs Revenue Market Share by Type (2027-2032) Table 37. Global Imatinib Mesylate Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Imatinib Mesylate Drugs Sales by Type (2021-2026) & (k units) Table 39. Global Imatinib Mesylate Drugs Sales by Type (2027-2032) & (k units) Table 40. Global Imatinib Mesylate Drugs Sales Market Share by Type (2021-2026) Table 41. Global Imatinib Mesylate Drugs Sales Market Share by Type (2027-2032) Table 42. Global Imatinib Mesylate Drugs Price by Type (2021-2026) & (US$/unit) Table 43. Global Imatinib Mesylate Drugs Price by Type (2027-2032) & (US$/unit) Table 44. Global Imatinib Mesylate Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Imatinib Mesylate Drugs Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Imatinib Mesylate Drugs Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Imatinib Mesylate Drugs Revenue Market Share by Application (2021-2026) Table 48. Global Imatinib Mesylate Drugs Revenue Market Share by Application (2027-2032) Table 49. Global Imatinib Mesylate Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Imatinib Mesylate Drugs Sales by Application (2021-2026) & (k units) Table 51. Global Imatinib Mesylate Drugs Sales by Application (2027-2032) & (k units) Table 52. Global Imatinib Mesylate Drugs Sales Market Share by Application (2021-2026) Table 53. Global Imatinib Mesylate Drugs Sales Market Share by Application (2027-2032) Table 54. Global Imatinib Mesylate Drugs Price by Application (2021-2026) & (US$/unit) Table 55. Global Imatinib Mesylate Drugs Price by Application (2027-2032) & (US$/unit) Table 56. Novartis Company Information Table 57. Novartis Business Overview Table 58. Novartis Imatinib Mesylate Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Novartis Imatinib Mesylate Drugs Product Portfolio Table 60. Novartis Recent Development Table 61. North America Imatinib Mesylate Drugs Revenue by Type (2021-2026) & (US$ Million) Table 62. North America Imatinib Mesylate Drugs Revenue by Type (2027-2032) & (US$ Million) Table 63. North America Imatinib Mesylate Drugs Sales by Type (2021-2026) & (k units) Table 64. North America Imatinib Mesylate Drugs Sales by Type (2027-2032) & (k units) Table 65. North America Imatinib Mesylate Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 66. North America Imatinib Mesylate Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 67. North America Imatinib Mesylate Drugs Revenue by Application (2021-2026) & (US$ Million) Table 68. North America Imatinib Mesylate Drugs Revenue by Application (2027-2032) & (US$ Million) Table 69. North America Imatinib Mesylate Drugs Sales by Application (2021-2026) & (k units) Table 70. North America Imatinib Mesylate Drugs Sales by Application (2027-2032) & (k units) Table 71. North America Imatinib Mesylate Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 72. North America Imatinib Mesylate Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 73. North America Imatinib Mesylate Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Imatinib Mesylate Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 75. North America Imatinib Mesylate Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 76. North America Imatinib Mesylate Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 77. North America Imatinib Mesylate Drugs Sales by Country (2021-2026) & (k units) Table 78. North America Imatinib Mesylate Drugs Sales by Country (2027-2032) & (k units) Table 79. North America Imatinib Mesylate Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 80. North America Imatinib Mesylate Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 81. United States Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 82. Canada Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 83. Mexico Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 84. Europe Imatinib Mesylate Drugs Revenue by Type (2021-2026) & (US$ Million) Table 85. Europe Imatinib Mesylate Drugs Revenue by Type (2027-2032) & (US$ Million) Table 86. Europe Imatinib Mesylate Drugs Sales by Type (2021-2026) & (k units) Table 87. Europe Imatinib Mesylate Drugs Sales by Type (2027-2032) & (k units) Table 88. Europe Imatinib Mesylate Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 89. Europe Imatinib Mesylate Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 90. Europe Imatinib Mesylate Drugs Revenue by Application (2021-2026) & (US$ Million) Table 91. Europe Imatinib Mesylate Drugs Revenue by Application (2027-2032) & (US$ Million) Table 92. Europe Imatinib Mesylate Drugs Sales by Application (2021-2026) & (k units) Table 93. Europe Imatinib Mesylate Drugs Sales by Application (2027-2032) & (k units) Table 94. Europe Imatinib Mesylate Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 95. Europe Imatinib Mesylate Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 96. Europe Imatinib Mesylate Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Imatinib Mesylate Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 98. Europe Imatinib Mesylate Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 99. Europe Imatinib Mesylate Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 100. Europe Imatinib Mesylate Drugs Sales by Country (2021-2026) & (k units) Table 101. Europe Imatinib Mesylate Drugs Sales by Country (2027-2032) & (k units) Table 102. Europe Imatinib Mesylate Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 103. Europe Imatinib Mesylate Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 104. Germany Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 105. France Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 106. U.K. Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 107. Italy Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 108. Russia Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 109. Spain Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 110. Netherlands Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 111. Switzerland Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 112. Sweden Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 113. Poland Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 114. China Imatinib Mesylate Drugs Revenue by Type (2021-2026) & (US$ Million) Table 115. China Imatinib Mesylate Drugs Revenue by Type (2027-2032) & (US$ Million) Table 116. China Imatinib Mesylate Drugs Sales by Type (2021-2026) & (k units) Table 117. China Imatinib Mesylate Drugs Sales by Type (2027-2032) & (k units) Table 118. China Imatinib Mesylate Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 119. China Imatinib Mesylate Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 120. China Imatinib Mesylate Drugs Revenue by Application (2021-2026) & (US$ Million) Table 121. China Imatinib Mesylate Drugs Revenue by Application (2027-2032) & (US$ Million) Table 122. China Imatinib Mesylate Drugs Sales by Application (2021-2026) & (k units) Table 123. China Imatinib Mesylate Drugs Sales by Application (2027-2032) & (k units) Table 124. China Imatinib Mesylate Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 125. China Imatinib Mesylate Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 126. Asia Imatinib Mesylate Drugs Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Imatinib Mesylate Drugs Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Imatinib Mesylate Drugs Sales by Type (2021-2026) & (k units) Table 129. Asia Imatinib Mesylate Drugs Sales by Type (2027-2032) & (k units) Table 130. Asia Imatinib Mesylate Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 131. Asia Imatinib Mesylate Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 132. Asia Imatinib Mesylate Drugs Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Imatinib Mesylate Drugs Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Imatinib Mesylate Drugs Sales by Application (2021-2026) & (k units) Table 135. Asia Imatinib Mesylate Drugs Sales by Application (2027-2032) & (k units) Table 136. Asia Imatinib Mesylate Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 137. Asia Imatinib Mesylate Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 138. Asia Imatinib Mesylate Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Imatinib Mesylate Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Asia Imatinib Mesylate Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Asia Imatinib Mesylate Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 142. Asia Imatinib Mesylate Drugs Sales by Country (2021-2026) & (k units) Table 143. Asia Imatinib Mesylate Drugs Sales by Country (2027-2032) & (k units) Table 144. Asia Imatinib Mesylate Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 145. Asia Imatinib Mesylate Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 146. Japan Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 147. South Korea Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 148. India Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 149. Australia Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 150. Taiwan Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 151. Southeast Asia Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 152. SAMEA Imatinib Mesylate Drugs Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Imatinib Mesylate Drugs Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Imatinib Mesylate Drugs Sales by Type (2021-2026) & (k units) Table 155. SAMEA Imatinib Mesylate Drugs Sales by Type (2027-2032) & (k units) Table 156. SAMEA Imatinib Mesylate Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 157. SAMEA Imatinib Mesylate Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 158. SAMEA Imatinib Mesylate Drugs Revenue by Application (2021-2026) & (US$ Million) Table 159. SAMEA Imatinib Mesylate Drugs Revenue by Application (2027-2032) & (US$ Million) Table 160. SAMEA Imatinib Mesylate Drugs Sales by Application (2021-2026) & (k units) Table 161. SAMEA Imatinib Mesylate Drugs Sales by Application (2027-2032) & (k units) Table 162. SAMEA Imatinib Mesylate Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 163. SAMEA Imatinib Mesylate Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 164. SAMEA Imatinib Mesylate Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA Imatinib Mesylate Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. SAMEA Imatinib Mesylate Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. SAMEA Imatinib Mesylate Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 168. SAMEA Imatinib Mesylate Drugs Sales by Country (2021-2026) & (k units) Table 169. SAMEA Imatinib Mesylate Drugs Sales by Country (2027-2032) & (k units) Table 170. SAMEA Imatinib Mesylate Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 171. SAMEA Imatinib Mesylate Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 172. Brazil Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 173. Argentina Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 174. Chile Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 175. Colombia Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 176. Peru Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 177. Saudi Arabia Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 178. Israel Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 179. UAE Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 180. Turkey Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 181. Iran Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 182. Egypt Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Imatinib Mesylate Drugs Distributors List Table 186. Imatinib Mesylate Drugs Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Imatinib Mesylate Drugs Image Figure 2. Global Imatinib Mesylate Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Imatinib Mesylate Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. 100mg Image Figure 5. 400mg Image Figure 6. Global Imatinib Mesylate Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Imatinib Mesylate Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Pharmacy Image Figure 10. Global Imatinib Mesylate Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Imatinib Mesylate Drugs Revenue (2021-2032) & (US$ Million) Figure 12. Global Imatinib Mesylate Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Imatinib Mesylate Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Imatinib Mesylate Drugs Revenue Market Share by Region (2021-2032) Figure 15. Global Imatinib Mesylate Drugs Sales (2021-2032) & (k units) Figure 16. Global Imatinib Mesylate Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Imatinib Mesylate Drugs Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Imatinib Mesylate Drugs Sales YoY (2021-2032) & (k units) Figure 19. Europe Imatinib Mesylate Drugs Sales YoY (2021-2032) & (k units) Figure 20. China Imatinib Mesylate Drugs Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Imatinib Mesylate Drugs Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Imatinib Mesylate Drugs Sales YoY (2021-2032) & (k units) Figure 23. Global Imatinib Mesylate Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Imatinib Mesylate Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Imatinib Mesylate Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Imatinib Mesylate Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Imatinib Mesylate Drugs Revenue Market Share by Type (2021-2032) Figure 29. Global Imatinib Mesylate Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Imatinib Mesylate Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Imatinib Mesylate Drugs Sales Market Share by Type (2021-2032) Figure 32. Global Imatinib Mesylate Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Imatinib Mesylate Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Imatinib Mesylate Drugs Revenue Market Share by Application (2021-2032) Figure 35. Global Imatinib Mesylate Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Imatinib Mesylate Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Imatinib Mesylate Drugs Sales Market Share by Application (2021-2032) Figure 38. North America Imatinib Mesylate Drugs Revenue Share by Type (2021-2032) Figure 39. North America Imatinib Mesylate Drugs Sales Share by Type (2021-2032) Figure 40. North America Imatinib Mesylate Drugs Revenue Share by Application (2021-2032) Figure 41. North America Imatinib Mesylate Drugs Sales Share by Application (2021-2032) Figure 42. North America Imatinib Mesylate Drugs Revenue Share by Country (2021-2032) Figure 43. North America Imatinib Mesylate Drugs Sales Share by Country (2021-2032) Figure 44. Europe Imatinib Mesylate Drugs Revenue Share by Type (2021-2032) Figure 45. Europe Imatinib Mesylate Drugs Sales Share by Type (2021-2032) Figure 46. Europe Imatinib Mesylate Drugs Revenue Share by Application (2021-2032) Figure 47. Europe Imatinib Mesylate Drugs Sales Share by Application (2021-2032) Figure 48. Europe Imatinib Mesylate Drugs Revenue Share by Country (2021-2032) Figure 49. Europe Imatinib Mesylate Drugs Sales Share by Country (2021-2032) Figure 50. China Imatinib Mesylate Drugs Revenue Share by Type (2021-2032) Figure 51. China Imatinib Mesylate Drugs Sales Share by Type (2021-2032) Figure 52. China Imatinib Mesylate Drugs Revenue Share by Application (2021-2032) Figure 53. China Imatinib Mesylate Drugs Sales Share by Application (2021-2032) Figure 54. Asia Imatinib Mesylate Drugs Revenue Share by Type (2021-2032) Figure 55. Asia Imatinib Mesylate Drugs Sales Share by Type (2021-2032) Figure 56. Asia Imatinib Mesylate Drugs Revenue Share by Application (2021-2032) Figure 57. Asia Imatinib Mesylate Drugs Sales Share by Application (2021-2032) Figure 58. Asia Imatinib Mesylate Drugs Revenue Share by Country (2021-2032) Figure 59. Asia Imatinib Mesylate Drugs Sales Share by Country (2021-2032) Figure 60. SAMEA Imatinib Mesylate Drugs Revenue Share by Type (2021-2032) Figure 61. SAMEA Imatinib Mesylate Drugs Sales Share by Type (2021-2032) Figure 62. SAMEA Imatinib Mesylate Drugs Revenue Share by Application (2021-2032) Figure 63. SAMEA Imatinib Mesylate Drugs Sales Share by Application (2021-2032) Figure 64. SAMEA Imatinib Mesylate Drugs Revenue Share by Country (2021-2032) Figure 65. SAMEA Imatinib Mesylate Drugs Sales Share by Country (2021-2032) Figure 66. Imatinib Mesylate Drugs Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Imatinib Mesylate Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • 400mg
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Imatinib Mesylate Drugs Market by Type
  3. 1.2.1 Global Imatinib Mesylate Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 100mg
  5. 1.2.3 400mg
  6. 1.3 Imatinib Mesylate Drugs Market by Application
  7. 1.3.1 Global Imatinib Mesylate Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Pharmacy
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Imatinib Mesylate Drugs Market Dynamics
  1. 2.1 Imatinib Mesylate Drugs Industry Trends
  2. 2.2 Imatinib Mesylate Drugs Industry Drivers
  3. 2.3 Imatinib Mesylate Drugs Industry Opportunities and Challenges
  4. 2.4 Imatinib Mesylate Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Imatinib Mesylate Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Imatinib Mesylate Drugs Revenue by Region
  3. 3.2.1 Global Imatinib Mesylate Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Imatinib Mesylate Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Imatinib Mesylate Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Imatinib Mesylate Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Imatinib Mesylate Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Imatinib Mesylate Drugs Sales by Region
  9. 3.4.1 Global Imatinib Mesylate Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Imatinib Mesylate Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Imatinib Mesylate Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Imatinib Mesylate Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Imatinib Mesylate Drugs Revenue by Manufacturers
  2. 4.1.1 Global Imatinib Mesylate Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Imatinib Mesylate Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Imatinib Mesylate Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Imatinib Mesylate Drugs Sales by Manufacturers
  6. 4.2.1 Global Imatinib Mesylate Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Imatinib Mesylate Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Imatinib Mesylate Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Imatinib Mesylate Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Imatinib Mesylate Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Imatinib Mesylate Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Imatinib Mesylate Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Imatinib Mesylate Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Imatinib Mesylate Drugs Market CR5 and HHI
  16. 4.8.2 2025 Imatinib Mesylate Drugs Tier 1, Tier 2, and Tier 3
5 Imatinib Mesylate Drugs Market by Type
  1. 5.1 Global Imatinib Mesylate Drugs Revenue by Type
  2. 5.1.1 Global Imatinib Mesylate Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Imatinib Mesylate Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Imatinib Mesylate Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Imatinib Mesylate Drugs Sales by Type
  6. 5.2.1 Global Imatinib Mesylate Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Imatinib Mesylate Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Imatinib Mesylate Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Imatinib Mesylate Drugs Price by Type
6 Imatinib Mesylate Drugs Market by Application
  1. 6.1 Global Imatinib Mesylate Drugs Revenue by Application
  2. 6.1.1 Global Imatinib Mesylate Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Imatinib Mesylate Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Imatinib Mesylate Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Imatinib Mesylate Drugs Sales by Application
  6. 6.2.1 Global Imatinib Mesylate Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Imatinib Mesylate Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Imatinib Mesylate Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Imatinib Mesylate Drugs Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Imatinib Mesylate Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Imatinib Mesylate Drugs Product Portfolio
  6. 7.1.5 Novartis Recent Developments
8 North America
  1. 8.1 North America Imatinib Mesylate Drugs Market Size by Type
  2. 8.1.1 North America Imatinib Mesylate Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Imatinib Mesylate Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Imatinib Mesylate Drugs Price by Type (2021-2032)
  5. 8.2 North America Imatinib Mesylate Drugs Market Size by Application
  6. 8.2.1 North America Imatinib Mesylate Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Imatinib Mesylate Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Imatinib Mesylate Drugs Price by Application (2021-2032)
  9. 8.3 North America Imatinib Mesylate Drugs Market Size by Country
  10. 8.3.1 North America Imatinib Mesylate Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Imatinib Mesylate Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Imatinib Mesylate Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Imatinib Mesylate Drugs Market Size by Type
  2. 9.1.1 Europe Imatinib Mesylate Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Imatinib Mesylate Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Imatinib Mesylate Drugs Price by Type (2021-2032)
  5. 9.2 Europe Imatinib Mesylate Drugs Market Size by Application
  6. 9.2.1 Europe Imatinib Mesylate Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Imatinib Mesylate Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Imatinib Mesylate Drugs Price by Application (2021-2032)
  9. 9.3 Europe Imatinib Mesylate Drugs Market Size by Country
  10. 9.3.1 Europe Imatinib Mesylate Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Imatinib Mesylate Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Imatinib Mesylate Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Imatinib Mesylate Drugs Market Size by Type
  2. 10.1.1 China Imatinib Mesylate Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Imatinib Mesylate Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Imatinib Mesylate Drugs Price by Type (2021-2032)
  5. 10.2 China Imatinib Mesylate Drugs Market Size by Application
  6. 10.2.1 China Imatinib Mesylate Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Imatinib Mesylate Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Imatinib Mesylate Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Imatinib Mesylate Drugs Market Size by Type
  2. 11.1.1 Asia Imatinib Mesylate Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Imatinib Mesylate Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Imatinib Mesylate Drugs Price by Type (2021-2032)
  5. 11.2 Asia Imatinib Mesylate Drugs Market Size by Application
  6. 11.2.1 Asia Imatinib Mesylate Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Imatinib Mesylate Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Imatinib Mesylate Drugs Price by Application (2021-2032)
  9. 11.3 Asia Imatinib Mesylate Drugs Market Size by Country
  10. 11.3.1 Asia Imatinib Mesylate Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Imatinib Mesylate Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Imatinib Mesylate Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Imatinib Mesylate Drugs Market Size by Type
  2. 12.1.1 SAMEA Imatinib Mesylate Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Imatinib Mesylate Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Imatinib Mesylate Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Imatinib Mesylate Drugs Market Size by Application
  6. 12.2.1 SAMEA Imatinib Mesylate Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Imatinib Mesylate Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Imatinib Mesylate Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Imatinib Mesylate Drugs Market Size by Country
  10. 12.3.1 SAMEA Imatinib Mesylate Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Imatinib Mesylate Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Imatinib Mesylate Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Imatinib Mesylate Drugs Value Chain Analysis
  2. 13.1.1 Imatinib Mesylate Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Imatinib Mesylate Drugs Production Mode & Process
  6. 13.2 Imatinib Mesylate Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Imatinib Mesylate Drugs Distributors
  9. 13.2.3 Imatinib Mesylate Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst